Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Bicalutamide

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 715Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    The French speciality pharmaceutical, Juvisé acquires two onco products from AZ
    The French speciality pharmaceutical, Juvisé acquires two onco products from AZ

    20 Dec 2020

    // PRESS RELEASE

    https://www.juvisepharmaceuticals.com/wp-content/uploads/2020/04/Press-Release-Dartmouth-20122019-Eng-Juvis%C3%A9-Final.pdf

    PRESS RELEASE
    20 Dec 2020
    Share Share
    AstraZeneca sells Amrimidx and Casodex European rights to Juvise
    AstraZeneca sells Amrimidx and Casodex European rights to Juvise

    21 Dec 2019

    // PHARMAFILE

    http://www.pharmafile.com/news/536087/astrazeneca-sells-amrimidx-and-casodex-european-rights-juvis-pharmaceuticals

    PHARMAFILE
    21 Dec 2019
    Share Share
    Pfizer, Astellas' Xtandi racks up more data for new prostate cancer approval
    Pfizer, Astellas' Xtandi racks up more data for new prostate cancer approval

    03 Jun 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/asco-pfizer-astellas-xtandi-racks-up-more-data-for-new-prostate-cancer-use

    Carly Helfand FIERCE PHARMA
    03 Jun 2019
    Share Share
    Anvisa Suspends Batch of Casodex (bicalutamide) 50mg
    Anvisa Suspends Batch of Casodex (bicalutamide) 50mg

    24 Feb 2018

    // ANVISA

    https://www.pharmacompass.com/pdf/news/anvisa-suspends-batch-of-casodex-bicalutamide-50mg-1519448434.pdf

    ANVISA
    24 Feb 2018
    Share Share
    ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million
    ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million

    30 Dec 2017

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ani-pharmaceuticals-acquires-four-ndas-from-astrazeneca-for-465-million-300576084.html

    PR NEWSWIRE
    30 Dec 2017
    Share Share
    AZ books 3 percent sales drop for Q3
    AZ books 3 percent sales drop for Q3

    09 Nov 2017

    // Zachary Brennan PHARMA TIMES

    http://www.pharmatimes.com/news/az_books_3_percent_sales_drop_for_q3_1210956

    Zachary Brennan PHARMA TIMES
    09 Nov 2017
    Share Share